References
- Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M. The pharmacological profile of a novel norpregnane progestin (trimegestone). Gynecol Endocrinol 1999;13:316–26
- Zhang Z, Lundeen SG, Zhu Y, Carver JM, Winneker RC. In vitro characterization of trime-gestone: a new potent and selective progestin. Steroids 2000;65:637–43
- Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Attinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med 1992;117: 1016–37
- Dunnett CV. A multiple comparison procedure for comparing several treatments with a control. Am Stat Assoc J 1955;50:1096–121
- Kalu DN, Liu CC, Hardin RR, Hollis BW. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 1989;124:7–16
- Wronski TJ, Yen CF. The ovariectomized rat as an animal model for postmenopausalbone loss. Cells and Materials 1991;Suppl 1:69–74
- Shapira D, Lotan-Miller R, Barzilai D, Silbermann M. The rat as a model for studies of the ageing skeleton. Cells and Materials 1991;Suppl 1:181–8
- Wronski TJ, Dann LM, Scott KS, Cintron M. Long-term effects of ovariectomy and ageing on the rat skeleton. Calcif Tissue Int 1989;45:360–6
- Abe T, Chow JWM, Lean JM, Chambers TJ. Estrogen does not restore bone loss after ovariectomy in the rat. J Bone Min Res 1993;8:831–8